276 related articles for article (PubMed ID: 26847562)
21. [Synchronous and metachronous carcinomas of the large intestine].
Vitale M; Morino M; Zan S; Coda A; Comoglio S; Contessa L
Minerva Chir; 1992 Jul; 47(13-14):1143-8. PubMed ID: 1508366
[TBL] [Abstract][Full Text] [Related]
22. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP
Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963
[TBL] [Abstract][Full Text] [Related]
23. Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center.
Hoej LB; Nykjær KM; Gronbaek H
ScientificWorldJournal; 2012; 2012():206350. PubMed ID: 23304081
[TBL] [Abstract][Full Text] [Related]
24. Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops.
Eriksson J; Norlén O; Ögren M; Garmo H; Ihre-Lundgren C; Hellman P
Scand J Surg; 2021 Mar; 110(1):44-50. PubMed ID: 31587594
[TBL] [Abstract][Full Text] [Related]
25. Familial risk of small intestinal carcinoid and adenocarcinoma.
Kharazmi E; Pukkala E; Sundquist K; Hemminki K
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):944-9. PubMed ID: 23500615
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
27. The association between cancers of the small and large bowel.
Neugut AI; Santos J
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):551-3. PubMed ID: 8268772
[TBL] [Abstract][Full Text] [Related]
28. Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013-2015.
Genus TSE; Bouvier C; Wong KF; Srirajaskanthan R; Rous BA; Talbot DC; Valle JW; Khan M; Pearce N; Elshafie M; Reed NS; Morgan E; Deas A; White C; Huws D; Ramage J
Br J Cancer; 2019 Nov; 121(11):966-972. PubMed ID: 31649320
[TBL] [Abstract][Full Text] [Related]
29. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
[TBL] [Abstract][Full Text] [Related]
30. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.
Willem H; Jooste V; Boussari O; Romain G; Bouvier AM
Eur J Cancer Prev; 2019 May; 28(3):167-172. PubMed ID: 29738323
[TBL] [Abstract][Full Text] [Related]
31. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
[TBL] [Abstract][Full Text] [Related]
32. [Incidence of treatment modalities for cancer of the small intestine in Burgundy (France)].
Barraya R; Benhamiche AM; Rassiat E; Phelip JM; Jouve JL; Faivre J
Gastroenterol Clin Biol; 1999 Feb; 23(2):215-20. PubMed ID: 10353016
[TBL] [Abstract][Full Text] [Related]
33. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
34. Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac Disease.
Emilsson L; Semrad C; Lebwohl B; Green PHR; Ludvigsson JF
Gastroenterology; 2020 Nov; 159(5):1686-1694.e2. PubMed ID: 32679218
[TBL] [Abstract][Full Text] [Related]
35. Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy.
Gustafsson BI; Siddique L; Chan A; Dong M; Drozdov I; Kidd M; Modlin IM
Int J Oncol; 2008 Dec; 33(6):1121-31. PubMed ID: 19020744
[TBL] [Abstract][Full Text] [Related]
36. Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors.
Verrico M; Rossi L; Tomao S; Colonna M; Vici P; Tomao F
Oncology; 2020; 98(1):10-15. PubMed ID: 31505502
[TBL] [Abstract][Full Text] [Related]
37. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of the TNM-classification for small bowel cancer.
Contant CM; Damhuis RA; van Geel AN; van Eijck CH; Wiggers T
Hepatogastroenterology; 1997; 44(14):430-4. PubMed ID: 9164514
[TBL] [Abstract][Full Text] [Related]
39. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study.
Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H
Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604
[TBL] [Abstract][Full Text] [Related]
40. The incidence and prognosis of patients with bacteremia.
Nielsen SL
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
